Chemistry42
PulseAugur coverage of Chemistry42 — every cluster mentioning Chemistry42 across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Insilico Medicine uses AI to accelerate drug discovery, licensing platform to top pharma
Insilico Medicine is leveraging generative AI to significantly accelerate and reduce the cost of drug discovery. The company has successfully used its AI platform to design a drug candidate that advanced to phase 2 clin…
-
Insilico Medicine advances AI-discovered drug rentosertib to Phase III trials for IPF
Insilico Medicine is moving its AI-discovered drug, rentosertib, into Phase III clinical trials for idiopathic pulmonary fibrosis (IPF). The drug, which targets the TNIK protein, showed promising results in Phase II tri…
-
Takeda partners with Insilico Medicine for $600M AI drug discovery deal
Takeda Pharmaceutical Company has entered into a strategic collaboration with Insilico Medicine, utilizing AI for early-stage drug discovery. The deal, potentially worth up to US$600 million, grants Takeda exclusive wor…